EBIO - Enthesitis Biopsy Study

Summary

The purpose of this Phase IV study is to determine the effect of secukinumab on total immune cell numbers obtaines by entheseal biopsy in the inflamed human entheses in patients with Psoriatic Arthritis. This is a single arm, single centre, prospective, open label study with secukinumab.

Timeline

Start

2019-03-18

Primary completion

2022-03

Completion

2022-09

Drugs

Indications